Americans are waking up to the fact that we’ve been tolerating unacceptable failure rates for drugs that are supposed to be safe and effective.
Featuring:
– Reshma Ramachandran, M.D., Assistant Professor of Medicine and Co-Director of Yale CRRIT, Yale School of Medicine
– Marta Wosińska, Ph.D., Senior Fellow, Center on Health Policy, The Brookings Institution
– Emma Yasinski, Senior Reporter, MedShadow Foundation (moderator)
Join this discussion that examines the changes and incentives needed to improve the drug system’s quality control and supply chains, and ensure everyone can access safe, reliable generic drugs.
